Encompass Health (NYSE:EHC) Updates FY 2025 Earnings Guidance

Encompass Health (NYSE:EHC) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 4.670-4.960 for the period, compared to the consensus estimate of 4.770. The company issued revenue guidance of $5.8 billion-$5.9 billion, compared to the consensus revenue estimate of $5.8 billion.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the company. StockNews.com lowered Encompass Health from a “buy” rating to a “hold” rating in a research report on Friday. Truist Financial restated a “buy” rating and set a $116.00 price target (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Royal Bank of Canada raised their price objective on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. KeyCorp boosted their target price on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Finally, William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research note on Friday. One analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $107.33.

Encompass Health Price Performance

Shares of NYSE EHC opened at $99.86 on Friday. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $10.06 billion, a PE ratio of 22.39, a P/E/G ratio of 1.18 and a beta of 0.90. The firm has a fifty day simple moving average of $96.28 and a 200 day simple moving average of $95.19. Encompass Health has a twelve month low of $72.37 and a twelve month high of $104.55.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%. On average, sell-side analysts forecast that Encompass Health will post 4.76 EPS for the current year.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.